Your participation in the 2026 AACI/AACR Hill Day is crucial to sharing our message with our legislators in Washington: that stable, predictable funds for the National Institutes of Health and National Cancer Institute are critical for advancing cancer research and care at our nation’s cancer centers. We encourage each cancer center to send at least one representative to Washington to advocate on your center’s behalf.
AACI Update | May 2026
Headlines
Cancer Center at Illinois Earns NCI Designation
The Cancer Center at Illinois (CCIL) has received designation from the National Cancer Institute (NCI), making it the nation’s 74th NCI-Designated Cancer Center and the 8th Basic Cancer Center to earn designation. Rather than treating patients, Basic Cancer Centers focus on the discovery and development of innovative approaches to cancer detection, treatment, and prevention. Rohit Bhargava, PhD, is the Phillip and Ann Sharp Director of CCIL.
Ovarian Cancer Physician and Researcher to Lead Neal Cancer Center
In April, following a national search, Daniela Matei, MD, became the new director of Houston Methodist Dr. Mary and Ron Neal Cancer Center. An expert in ovarian cancer treatment and research, Dr. Matei previously served as chief of the Division of Reproductive Science in Medicine in the Department of Obstetrics and Gynecology at Northwestern University Feinberg School of Medicine and led the Translational Research in Malignancies Program at Northwestern's Robert H. Lurie Comprehensive Cancer Center.
Steidl Named Director of Montefiore Einstein Comprehensive Cancer Center
Ulrich Steidl, MD, PhD, an international leader in blood cancer and stem cell research, has been named director of the Montefiore Einstein Comprehensive Cancer Center (MECCC) and vice president of cancer medicine at Montefiore Einstein. He previously served as interim director of MECCC, a role he took on in late 2025 after the passing of Director Edward Chu, MD, MMS.
Childhood Cancer Expert Named Director of UW Carbone Cancer Center
Christian Capitini, MD, a national expert in the treatment and research of childhood cancers, is the new director of the University of Wisconsin Carbone Cancer Center. He formally assumed the role in April, after serving as acting director since December 2024. Dr. Capitini is also a pediatric hematologist and oncologist with UW Health Kids at the American Family Children’s Hospital. His research focuses on stem cell transplant and personalized cellular therapies.
Baldwin, Capito to Receive Cancer Research Ally Award
Senators Tammy Baldwin (D-WI) and Shelley Moore Capito (R-WV) will be honored with the Cancer Research Ally Award during an evening reception on Wednesday, May 13, before the 2026 AACI/AACR Hill Day in Washington, DC. Sens. Baldwin and Capito serve as the ranking member and chair, respectively, of the Labor, Health and Human Services, Education and Related Agencies Appropriations Subcommittee.
Register Today: 2026 AACI/CCAF Annual Meeting and Pre-Event Meetings
Registration is now open for the 2026 AACI/CCAF Annual Meeting, which will take place October 25-27 at the Chicago Marriott Downtown Magnificent Mile, and for two pre-event meetings: the AACI Leadership Development Workshop and the Impact Summit. The early registration rate is available through Sunday, May 17.
Abstract Winners Announced for 18th Annual AACI CRI Meeting
The AACI Clinical Research Innovation (CRI) Steering Committee, with the assistance of peer reviewers from the CRI community, has selected four abstracts from 162 submissions for formal presentation at the 18th Annual AACI CRI Meeting, June 23-25, at the Loews Chicago O'Hare Hotel in Rosemont, IL. Winning abstract authors represent UF Health Cancer Institute; OHSU Knight Cancer Institute; Laura and Isaac Perlmutter Cancer Center at NYU Langone Health; and Moffitt Cancer Center.
PCLI Webinar: Medical-Legal Partnerships in Cancer Care
AACI's Physician Clinical Leadership Initiative (PCLI) will host a webinar titled "Medical-Legal Partnerships: Breaking Barriers in Cancer Care" at 2:00 pm eastern time on Tuesday, June 9. Attendees will explore the role of medical-legal partnerships (MLPs) in cancer care, the history and evolution of the model, and how MLPs can be integrated into cancer centers to better support patients and advance patient-centered care.
AACI Names Medlive Exclusive Digital Education Partner
AACI has named Medlive its exclusive digital education partner. The partnership is designed to support AACI's mission by ensuring that emerging science reaches the clinicians who need it most. Medlive will provide a scalable, video-first platform to support our education initiatives, with programming informed by clinician engagement and evolving data insights.
Explore Our Programs
News from the Centers
Evers to Lead American Surgical Association
UK Markey Cancer Center
B. Mark Evers, MD, director of UK Markey Cancer Center, has been named president-elect of the American Surgical Association (ASA). A surgical oncologist and physician-scientist with more than three decades of research and clinical experience, Dr. Evers will help guide the ASA in its mission to advance surgical science, education and patient care across the nation. Dr. Evers is a member of AACI's Board of Directors.
Cao Named Guggenheim Fellow
Siteman Cancer Center
Yin Cao, ScD, MPH, has been named a 2026 Fellow of the John Simon Guggenheim Memorial Foundation, a prestigious honor recognizing her leadership in integrating data science, cancer etiology, and population health. She is a research member of Siteman Cancer Center.
Pancreatic Cancer Researcher Presents Byers Award Lecture
UCSF Helen Diller Family Comprehensive Cancer Center
Rushika Perera, PhD, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of UCSF’s Pancreas Center, presented the 2026 Byers Award Lecture in Basic Science – one of UCSF's highest honors for early- and mid-career scientists. Dr. Perera's work is creating new possibilities for cutting off the fuel supply for pancreatic cancer.
DiPersio Receives AACR Blood Cancer Research Award
Siteman Cancer Center
John F. DiPersio, MD, PhD, was honored by the American Association for Cancer Research (AACR) for decades of innovation that have transformed the understanding and treatment of hematologic malignancies.
Researcher Wins Big 12 Faculty of the Year Award
The University of Kansas Cancer Center
John Thyfault, PhD, professor of cell biology and physiology at the University of Kansas Medical Center and a nationally recognized leader in metabolism and exercise physiology, has been named KU’s winner of the 2025-2026 Big 12 Faculty of the Year Awards. Dr. Thyfault's interdisciplinary research examines the impact of obesity and metabolism on diseases, including cancer.
$8.2 Million NIH Grant Awarded to Investigate the Origins of Blood-Forming Stem Cells
Mount Sinai Tisch Cancer Center
Christopher Sturgeon, PhD, has been awarded an Outstanding Investigator Award (R35) from the National Heart, Lung, and Blood Institute to investigate the earliest developmental origins of the hematopoietic system – the network of organs and tissues responsible for producing blood cells. This work aims to uncover the signals and genetic programs that govern blood formation.
Researchers Establish New Digital Engagement and Cancer Outcomes Center With ACS Grant
Karmanos Cancer Institute, Wayne State University
Wayne State University and the Karmanos Cancer Institute researchers have secured a four-year, $4.07 million American Cancer Society (ACS) Cancer Health Research Center grant to establish the Digital Engagement and Cancer Outcomes Center. One of the center's goals is to better understand the impact of the digital environment and digital inclusion on outcomes and disparities among Black cancer patients, survivors, and caregivers.
State Innovation Funds Target Rural Cancer Care
Tampa General Hospital Cancer Institute
With support from an almost $2 million award from the Florida Cancer Innovation Fund, the USF Health Morsani College of Medicine and the Tampa General Hospital Cancer Institute are leading a bold multidisciplinary initiative to eliminate geographic barriers to cervical cancer care, leveraging AI-driven technology to reach Florida’s rural populations.
DOD Award Supports Bladder Cancer Research
Hollings Cancer Center, Medical University of South Carolina
Daniel Sprague, MD, PhD, a drug discovery scientist at MUSC Hollings Cancer Center, received a four-year, $1.1 million Career Development Award from the U.S. Department of Defense (DOD) Peer-Reviewed Cancer Research Program to study mutations in the ARID1A gene. Loss of ARID1A is common in bladder cancer and associated with more aggressive forms of the disease.
Endowment Honors Clinical Science Delivered With Empathy
The University of Arizona Cancer Center
A $1 million gift from John and Valli Duval will provide enduring support for cancer research and clinical innovation at the University of Arizona Cancer Center. The gift established an endowed fund and the John F. and Valli S. Duval Endowed Professorship for Gastrointestinal Oncology at the University of Arizona College of Medicine – Tucson. Rachna Shroff, MD, MS, FASCO, will be the inaugural holder of the professorship. Dr. Shroff is a member of AACI's Physician Clinical Leadership Initiative Steering Committee.
$1 Million Received to Create Endowed Funds at Cancer Center
UAMS Winthrop P. Rockefeller Cancer Institute
The University of Arkansas for Medical Sciences (UAMS) received $500,000 from Helen Lang and Nick Lang, MD, and $500,000 from Kent C. Westbrook, MD, for the UAMS Winthrop P. Rockefeller Cancer Institute, both in honor of Westbrook’s late wife, Jonnie Kay Westbrook.
Chuckstrong Raises More Than $900,000 for Cancer Research
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
The 14th annual Chuckstrong Tailgate Gala raised more than $900,000 for research at the IU Simon Comprehensive Cancer Center. Held at the Indiana Farm Bureau Football Center, the 2026 Chuckstrong Tailgate Gala brought total giving to $17.7 million for cancer research since the Chuckstrong initiative launched in 2012.
Grant Will Address Gaps in Sexual Health Counseling for Female Rectal Cancer Patients
Fox Chase Cancer Center, Temple Health
Researchers at Fox Chase Cancer Center have been awarded a grant to study sexual dysfunction in female patients undergoing treatment for rectal cancer. With funding from the Colon Cancer Coalition, the study will look at women’s sexual needs and expectations before rectal cancer treatment, how treatment affects their sexual function, and how comfortable providers are talking about these issues.
Mendillo Appointed Associate Director for Education
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Marc Mendillo, PhD, has been appointed associate director for education at Lurie Cancer Center. This position supports the training and development of the next generation of cancer researchers and clinicians, a core expectation of NCI-Designated Cancer Centers.
Supportive Oncology Expert to Lead IU Center
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
An internationally recognized supportive oncology expert has joined the Indiana University Melvin and Bren Simon Comprehensive Cancer Center. Christian "Chris" Nelson, PhD, a clinical psychologist, has been named the director of the Walther Center for Supportive Oncology at the cancer center. In addition, he’ll serve as chief resilience officer at the cancer center.Passaglia Named Associate Director for Administration
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Lurie Cancer Center has named Carolyn Passaglia, MSRC, associate director for administration. In this role, Passaglia provides strategic leadership and operational oversight for the center’s administrative infrastructure, supporting its scientific programs, shared resources, clinical research, community engagement, and educational initiatives.
Cellular 'Neighborhoods' Inside Tumors May Predict Which Patients With Melanoma Benefit From Combination Immunotherapy
UCLA Jonsson Comprehensive Cancer Center
A UCLA Health Jonsson Comprehensive Cancer Center study suggests that the way immune cells are organized inside melanoma tumors may help explain which patients will benefit from combination immunotherapy after standard anti-PD-1 treatment stops working. The findings show that patients whose tumors contained active networks of cancer-killing T cells were more likely to benefit from treatment, while those with dense clusters of plasma cells were far less likely to benefit.
Blood-Based DNA Signals May Help Track Osteosarcoma in Children
The University of Chicago Medicine Comprehensive Cancer Center
Researchers from the University of Chicago Medicine and collaborating institutions have identified epigenetic signals—the chemical modifications on DNA that control whether genes are turned on or off—in fragments of circulating DNA in the blood that correlate with disease status in patients with osteosarcoma. These new findings suggest a potential new approach for tracking the disease using a simple blood test.
New Study Reveals How Obesity Biologically Contributes to Cancer Risk
Winship Cancer Institute of Emory University
A new scientific review examines how excess body fat may influence cancer development and what current evidence suggests about reducing risk. The paper synthesizes findings from large population studies, clinical trials, and laboratory research involving millions of patients worldwide. The authors report that overweight and obesity may contribute to roughly 10 percent of new cancer diagnoses each year in the United States.
Review Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments
Roswell Park Comprehensive Cancer Center
A new clinical review by physicians at Roswell Park Comprehensive Cancer Center provides an updated, evidence-based overview of endometrial cancer, highlighting rising incidence and mortality rates in the United States alongside advances in diagnosis, risk stratification, and personalized treatment.
Scientist Studies Where Brain Cancer Cells Hide and How to Fight Them
University of New Mexico Comprehensive Cancer Center
Sara G. M. Piccirillo, PhD, and her team found that in 65 percent of people with glioblastoma, unremoved tumor cells reside in the sub-ventricular zone. Its role as a reservoir of glioblastoma cells was described in their article, "Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma," published in Cell Reports.
New Scoring Tool Shows Radiation Can Reprogram Pancreatic Tumor Environment
Fox Chase Cancer Center, Temple Health
A new study from researchers at Fox Chase Cancer Center focusing on pancreatic cancer has shown that a new scoring system can provide a single numerical value that reflects whether the tumor microenvironment is working to suppress or support that tumor. The results of the laboratory study could ultimately help clinicians improve treatment offered to patients with pancreatic cancer.
Molecules Produced by Gut Microbes Linked to Colon Cancer Risk
Cedars-Sinai Cancer
Microbes in the gut use specialized chemical signaling molecules to communicate, and one day, these molecules may help doctors understand which ulcerative colitis patients are most likely to develop colon cancer. In a study co-led by researchers at Cedars-Sinai Health Sciences University, investigators found that the molecules—called quorum sensing molecules, or QSMs—are a link between the gut microbiome and cancer risk.
Pesticide Residue May Play Role in Increased Rates of Lung Cancer in Non-Smokers Under Age 50
USC Norris Comprehensive Cancer Center
New research from USC Norris Comprehensive Cancer Center suggests that a healthy diet rich in fruit, vegetables, and whole grains may put non-smoking Americans under the age of 50 at greater risk of developing lung cancer. Such foods are more likely to be associated with a higher residue of pesticides than dairy, meat, and many processed foods.
High Antibodies Create Disparities in Donor Search for Blood and Bone Marrow Transplants
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
People who have elevated levels of donor-specific anti-HLA antibodies wait an average of three additional months to receive blood or bone marrow transplants from a healthy donor, according to recent research from investigators at the Johns Hopkins Kimmel Cancer Center. Those most likely to be affected are Black women who have had prior pregnancies, researchers found, in work supported by the National Institutes of Health.
Researchers Identify Cellular Pathways That Drive Precancerous Lesions to Form Pancreatic Tumors
University of Michigan Rogel Cancer Center
Pancreatic ductal adenocarcinoma begins with a reversible state called acinar-to-ductal metaplasia, where cells can heal after injury or inflammation. In a new study, researchers identified cellular pathways that can influence metabolic changes when cells progress from metaplasia to cancer. Their results could help researchers treat benign lesions before they become tumors.
Investigators Turn Cancer Mutation Into a Chemical Handle for Precision 'Molecular Glues'
Winship Cancer Institute of Emory University
Researchers at Winship Cancer Institute of Emory University and Emory University School of Medicine have reported a significant advance in the development of next-generation anticancer therapeutics: a precision "molecular glue" strategy that converts previously undruggable cancer mutations into actionable drug targets.
Low-Cost Blood Test Developed to Detect Multiple Cancers and Other Diseases From a Single Sample
UCLA Jonsson Comprehensive Cancer Center
UCLA scientists have developed a simple and cost-effective blood test that, in early studies, shows promise in detecting multiple cancers, various liver conditions, and organ abnormalities simultaneously by analyzing DNA fragments circulating in the bloodstream. The test could offer a powerful and more affordable approach to early disease detection and comprehensive health monitoring.
Research Seeks to Determine if Circadian Disruption Increases Risk for a Type of Carcinoma
Fred Hutch Cancer Center
Liver cancers are commonly thought to be driven by heavy alcohol use or chronic hepatitis B or C virus infection. But a new grant awarded to Fred Hutch Cancer Center epidemiologist Trang VoPham, PhD, MPH, MS, will investigate whether the most common form of liver cancer―hepatocellular carcinoma―is also driven by something completely unrelated to alcohol use or viral infection: a disruption in circadian rhythms.
If You Haven't Heard of Lynch Syndrome You Are Not Alone
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF is the only site in California participating in a National Institutes of Health-sponsored clinical trial designed to prevent cancer in people with Lynch syndrome. Lynch syndrome affects about 1 in 279 people in the U.S. and significantly increases the lifetime risk of colorectal cancer and several other cancers.
Researchers Publish Review Defining 'Hallmarks of Liver Cancer'
Mount Sinai Tisch Cancer Center
Mount Sinai researchers Josep Llovet, MD, PhD, and Daniela Sia, PhD, led a new review that provides one of the clearest roadmaps to date for understanding and treating liver cancer. Published in Cell, the study, "Hallmarks of Liver Cancer: Therapeutic Implications," focuses on primary liver cancer and offers new insights into disease biology and treatment strategies.
Using Imaging to Measure Body Composition May Improve Cancer Risk Assessment in Postmenopausal Women
The University of Arizona Cancer Center
A new study led by a researcher at the University of Arizona Cancer Center found that higher levels of visceral fat in postmenopausal women were linked to a significantly higher risk of obesity-related cancers. The findings suggest that where fat is stored in the body may provide important information beyond traditional measures such as body mass index.
Real-World Data Show Targeted Therapy Extends Survival in Aggressive Form of Colorectal Cancer
Roswell Park Comprehensive Cancer Center
A new study from Roswell Park Comprehensive Cancer Center suggests that patients with HER2‑positive metastatic colorectal cancer may live longer when treated with the targeted therapy trastuzumab deruxtecan (T‑DXd, brand name Enhertu) compared to standard chemotherapy. The findings provide important evidence that the survival benefits previously seen in clinical trials also hold up in everyday cancer care.
Three Patients Treated With Novel Theranostics Drug in First-in-Human Clinical Trial
Huntsman Cancer Institute at the University of Utah
Huntsman Cancer Institute at the University of Utah has treated the first three patients in the world in a first-in-human clinical trial of RYZ401, a next-generation targeted therapy for neuroendocrine tumors and other solid tumors in the cutting-edge field of radiopharmaceuticals.
AML Mutation Initiates Primary Cancer, Not Required for Disease Maintenance
Stanford Cancer Institute
A new study has found DNMT3AR882 mutations are necessary for acute myeloid leukemia (AML) initiation but are largely dispensable for disease maintenance, observing that the notion that initiating oncogenes differ from those that maintain cancer has important implications for cancer evolution and therapy. Ravi Majeti, MD, PhD, is senior author of the article.
Tell FDA: Reconsider Allowing Flavored E-Cigarettes
Mays Cancer Center at UT Health San Antonio MD Anderson
Salud America!, part of the Institute for Health Promotion Research at UT Health San Antonio, has drafted a model public comment on the U.S. Food and Drug Administration's (FDA) plan to consider allowing some flavored e-cigarettes on the market. Any new vape flavors could only be marketed to adults, but public health leaders warn that the FDA's new guidance does not account for the toxicity of flavored e-cigarettes, particularly when used in conjunction with combusted cigarettes, and does not offer sufficient evidence of an added benefit to adults who smoke. Comments are due Monday, May 11.
Countdown Begins to Opening of AbbVie Foundation Cancer Pavilion
The University of Chicago Medicine Comprehensive Cancer Center
UChicago Medicine will open the AbbVie Foundation Cancer Pavilion, a first-of-its-kind freestanding facility on Chicago's South Side, in April 2027. Designed to redefine cancer care, research, and the patient experience, the 575,000-square-foot facility is among the largest and most ambitious projects in UChicago Medicine's history.
Inspiring a New Generation of Cancer Researchers
University of New Mexico Comprehensive Cancer Center
As part of its commitment to training the next generation of scientists, the UNM Comprehensive Cancer Center established the Cancer Research Training and Education Coordination Core (CRTECC) program for high school and middle school students. Jennifer Gillette, PhD (pictured in her lab with a CRTECC participant), is associate director of Education, Training and Mentoring.
How Rethinking the Basics Improved Wait Times for Abdominal Cancer Patients
Hollings Cancer Center, Medical University of South Carolina
MUSC Hollings Cancer Center Surgical Oncology Chief Kevin Roggin, MD, is reimagining clinic scheduling procedures to improve access for patients with hepato-pancreato-biliary and other abdominal cancers at MUSC Hollings Cancer Center. The goal of the Next-Day Access program is to give eligible patients the option to schedule an appointment within 48 hours.
USC, Tempus AI Form Strategic Collaboration
USC Norris Comprehensive Cancer Center
The Keck School of Medicine of USC and Keck Medicine of USC have launched collaborations with Tempus AI, Inc., a technology company at the forefront of applying artificial intelligence to precision medicine, to integrate clinical care, clinical trials, and research through a unified framework. The goal of this strategic collaboration, which will include the USC Norris Comprehensive Cancer Center, is to enhance patient care and accelerate research and innovation.
Endorse Comment on NIH Strategic Plan
Mays Cancer Center at UT Health San Antonio MD Anderson
Amelie G. Ramirez, DrPH, MPH, associate director of cancer outreach and engagement at Mays Cancer Center, is sharing a comment on 13 key areas that drive the Latino cancer burden as part of the National Institutes of Health (NIH) Strategic Plan for Fiscal Years 2027-2031. Endorsements are due by 11:59 pm eastern time on Tuesday, May 26.
Web Tool Helps Patients Share Genetic Testing Results With Family
University of Michigan Rogel Cancer Center
While oncologists focus on their patients, they rarely follow up with family members who may be at increased risk of cancer. A web-based intervention could help educate people with cancer about the impact genetic variants may have on their family. Researcher Steven J. Katz, MD, MPH, and colleagues at the University of Michigan Health Rogel Cancer Center developed the tool, called Genetic Information and Family Testing, or GIFT.
New Facility Offering Proton Therapy for Pediatric, Adult Cancer Patients
Stanford Cancer Institute
Stanford Medicine is opening a first-of-its-kind facility to deliver a form of radiation therapy that has been difficult for cancer patients to access. Stanford’s innovation—in collaboration with two medical technology companies—is to drastically shrink the size and cost of the machinery used to deliver proton therapy.
Cancer Center Jobs
Assistant Director, Clinical Research Operations
Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center
Read moreCancer Bioinformatics Co-Director
Hollings Cancer Center, Medical University of South Carolina
Read moreDirector, Department of Oncology (Chair)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Read moreGynecologic Oncology Physician
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Read moreSenior Director, Perlmutter Cancer Center Research Administration
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health
Read moreMeeting Announcements
2026 AACI/AACR Hill Day
May 14, 2026
2026 Inaugural Marrow Masterclass
May 16, 2026
8:00 AM - 3:00 PM
Comprehensive Myeloid, Leukemia & Bone Marrow Failure Symposium
This program is geared towards general physicians, surgeons, fellows, residents, students, pathologists, radiation oncologists, pharmacists, physician assistants, nurse practitioners and nurses in the field of hematology and oncology.
This activity has been approved for up to 6.25 AMA PRA Category 1 Credits™. Provided by Wayne State University School of Medicine and Karmanos Cancer Institute.
Rural Health and Cancer Conference
June 2, 2026
The Rural Health and Cancer Conference aims to improve rural cancer outcomes by convening a wide-array of experts from across the nation in rural cancer healthcare delivery and building cross-disciplinary collaborations amongst rural cancer health experts.
18th Annual AACI Clinical Research Innovation (CRI) Meeting
June 23, 2026
The 3-day CRI annual meeting includes panel discussions, breakout sessions, and presentations of abstracts and posters, which aim to establish best practices for cancer center clinical trials offices.
Support Opportunities
2026 AACI Leadership Development Workshop
October 24, 2026
The 2026 AACI Leadership Development Workshop will be held in conjunction with the 2026 AACI/CCAF Annual Meeting.
This event convenes emerging leaders for didactic and experiential leadership development sessions. An offshoot of Dr. Caryn Lerman’s AACI presidential initiative, the workshop aims to enhance the oncology leadership pipeline with top talent.
Support Opportunities
2026 Impact Summit
October 24, 2026
The 2026 Impact Summit will be held in conjunction with the 2026 AACI/CCAF Annual Meeting.
Co-hosted by AACI and the Cancer Center Network, the Impact Summit brings together cancer center leaders, researchers, and other stakeholders for a dynamic one-day event focused on strengthening the future of cancer center leadership and workforce development.
Support Opportunities
2026 New Cancer Center Directors Meeting
October 24, 2026
The 2026 New Cancer Center Directors Meeting will be held in conjunction with the 2026 AACI/CCAF Annual Meeting. Participation in this meeting is by invitation only.
2026 AACI/CCAF Annual Meeting
October 25, 2026
The 3-day AACI/CCAF annual meeting offers AACI members the opportunity to network with cancer center colleagues, national cancer research and advocacy groups, industry, and government health agencies to develop solutions to common challenges.
Support Opportunities